Wei-Shou Hwang
- Hepatology top 5%
-
- Colorectal Cancer Treatments and Studies 4
- Neutropenia and Cancer Infections 2
- Cancer Treatment and Pharmacology 2
- Pancreatic and Hepatic Oncology Research 1
-
- Acute Myeloid Leukemia Research 2
-
- Colorectal and Anal Carcinomas 2
-
- Gastric Cancer Management and Outcomes 2
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Co-authors
- Ann‐Lii ChengChiun HsuTsu-Yi ChaoSheng-Fung LinMing-Chih ChangPei‐Jer ChenChi-Cheng LiMing-Chung Wang
- Cited by
- HepatologyEpidemiologyOncology
- Partner nations
- TaiwanUnited StatesGermany
In The Last Decade
Wei-Shou Hwang
11 papers receiving 406 citations
Peers
Comparison fields: 5 of 48
- Hepatology 260
- Epidemiology 236
- Oncology 118
- Pathology and Forensic Medicine 37
- Hematology 20
Countries citing papers authored by Wei-Shou Hwang
This map shows the geographic impact of Wei-Shou Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Shou Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Shou Hwang more than expected).
Fields of papers citing papers by Wei-Shou Hwang
This network shows the impact of papers produced by Wei-Shou Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Shou Hwang. The network helps show where Wei-Shou Hwang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei-Shou Hwang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 5 | |
| 2 | 2013 | 3 | |
| 3 | 2012 | 83 | |
| 4 | Thalidomide for the treatment of myelodysplastic syndrome in Taiwan: results of a phase II trial. | 2012 | 8 |
| 5 | 2008 | 230 | |
| 6 | 2008 | 6 | |
| 7 | 2007 | 9 | |
| 8 | 2006 | 40 | |
| 9 | 2005 | 13 | |
| 10 | 1997 | 1 | |
| 11 | 1990 | 12 |
About Wei-Shou Hwang
Wei-Shou Hwang is a scholar working on Oncology, Hepatology and Genetics, having authored 11 papers that have together received 410 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (4 papers), Acute Myeloid Leukemia Research (2 papers), Neutropenia and Cancer Infections (2 papers), Colorectal and Anal Carcinomas (2 papers), Gastric Cancer Management and Outcomes (2 papers), Cancer Treatment and Pharmacology (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Hepatology (260 citations), Epidemiology (236 citations) and Oncology (118 citations). Wei-Shou Hwang has collaborated with scholars based in Taiwan, United States and Germany. Frequent co-authors include Ann‐Lii Cheng, Chiun Hsu, Tsu-Yi Chao, Sheng-Fung Lin, Ming-Chih Chang, Pei‐Jer Chen, Chi-Cheng Li, Ming-Chung Wang, Chao A. Hsiung and Yu-Min Liao. Their work appears in journals such as Hepatology, CHEST Journal and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.